180 related articles for article (PubMed ID: 18224443)
1. Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.
Cangiano J; Centeno BA; Garrett CR; Cáceres W; de Jesús A; Lee JH; Pavía O; Jove R; Báez L; Sullivan DM; Muro-Cacho CA; Muñoz-Antonia T
Dig Dis Sci; 2008 Aug; 53(8):2090-100. PubMed ID: 18224443
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma].
Song Y; Huang J; Wang JW
Chin J Cancer; 2010 Jan; 29(1):76-81. PubMed ID: 20038314
[TBL] [Abstract][Full Text] [Related]
3. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
[TBL] [Abstract][Full Text] [Related]
4. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
Peredo R; Sastre G; Serrano J; Hunter Mellado R
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1025-32. PubMed ID: 11785652
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.
Zhang XL; Yang YS; Xu DP; Qu JH; Guo MZ; Gong Y; Huang J
World J Surg; 2009 Oct; 33(10):2112-8. PubMed ID: 19636613
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis.
Jeung J; Patel R; Vila L; Wakefield D; Liu C
Arch Pathol Lab Med; 2012 Jun; 136(6):610-7. PubMed ID: 22646266
[TBL] [Abstract][Full Text] [Related]
8. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
[TBL] [Abstract][Full Text] [Related]
9. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.
Farzand S; Siddique T; Saba K; Bukhari MH
World J Gastroenterol; 2014 May; 20(19):5889-96. PubMed ID: 24914350
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Setia N; Ahn S; Han HS; Park DY; Lauwers GY
Hum Pathol; 2019 Dec; 94():64-70. PubMed ID: 31676362
[TBL] [Abstract][Full Text] [Related]
11. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604).
Saeki H; Oki E; Kashiwada T; Arigami T; Makiyama A; Iwatsuki M; Narita Y; Satake H; Matsuda Y; Sonoda H; Shimokawa M; Maehara Y;
Eur J Cancer; 2018 Dec; 105():41-49. PubMed ID: 30391779
[TBL] [Abstract][Full Text] [Related]
13. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
14. Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.
Madani SH; Rahmati A; Sadeghi E; Khazaei S; Sadeghi M; Payandeh M; Amirifard N
Asian Pac J Cancer Prev; 2015; 16(17):7755-8. PubMed ID: 26625793
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Cavalli S; Silini EM; Ardizzoni A
Br J Cancer; 2011 Apr; 104(9):1372-6. PubMed ID: 21487407
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer.
Wu Y; Mohamed H; Chillar R; Ali I; Clayton S; Slamon D; Vadgama JV
Breast Cancer Res; 2008; 10(1):R3. PubMed ID: 18184439
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of HER2/neu expression in gastric cancer.
Ananiev J; Gulubova M; Manolova I; Tchernev G
Wien Klin Wochenschr; 2011 Jul; 123(13-14):450-4. PubMed ID: 21739203
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of steroid receptors and HER 2/neu in breast cancer biopsies of women living in Puerto Rico.
Colón E; Reyes JS; González Keelan C; Climent-Peris C
P R Health Sci J; 2002 Dec; 21(4):299-303. PubMed ID: 12572236
[TBL] [Abstract][Full Text] [Related]
19. HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications.
Hechtman JF; Polydorides AD
Arch Pathol Lab Med; 2012 Jun; 136(6):691-7. PubMed ID: 22646280
[TBL] [Abstract][Full Text] [Related]
20. Laboratory testing for HER2/neu in breast carcinoma: an evolving strategy to predict response to targeted therapy.
Diaz NM
Cancer Control; 2001; 8(5):415-8. PubMed ID: 11579337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
